This table presents recent patent oppositions filed by Glenmark Life Sciences Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP1856051Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.Nov 13, 2019

The following table provides an overview of the latest patents of Glenmark Life Sciences Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3341359Mar 23, 2022Process For Preparation Of Apremilast1